Share this

Test Driving New Inhaled Insulin Afrezza

By Amy Tenderich on March 30, 2015

DiabetesMine Logo

I have been using Afrezza, the new inhaled insulin developed by MannKind and marketed by Sanofi, for the last three and a half weeks.

So far it’s… mysterious and exciting. Mysterious because the dosing seems ridiculously imprecise compared to the micro-unit counts I’m used with an insulin pump. And exciting because I’m finding that Dr. Steve Edelman was right – this stuff really does work extremely well!

Read the full post »


About DiabetesMine

Welcome to DiabetesMine — a gold mine of information and encouragement created by and for people impacted by diabetes, in the form of “a diabetes newspaper with a personal twist.”

Since its inception in 2005, DiabetesMine has won a number of awards and accolades, including the 2013 Sharecare / American Diabetes Association distinction of “No.1 diabetes influencer site in the country.”   Read more »

Subscribe to our newsletter »      Follow us on Twitter      Find us on Facebook      Contact us »

News nugget diabetes mine

Novo to Resubmit Tresiba Insulin to FDA
Data shows new long-acting insulin will not increase cardiovascular risk.

New #MedicareCoverCGM Legislation Introduced
U.S. House brings back bill to expand access of continuous glucose monitors for people on Medicare.

Why Isn't There Generic Insulin?
New Johns Hopkins study looks at history of insulin, reasons why there is no generic to compete with high-priced brands.

Latest Entries

Ask D'Mine: Weathering Mail Order Diabetes Supply Services

By WilD March 28, 2015
In our weekly diabetes advice column, Ask D'Mine, columnist Wil Dubois answers a big question about the "complications" that sometimes arise when using mail-order service to get our sensitive diabetes supplies...

When 'Real Person Sick' Is Hijacked by Diabetes

By MikeH on March 27, 2015
It's always amazing to me -- and so very frustrating -- how little other docs tend to listen to us, when we're trying to keep them on point about a particular non-D health issue and thell them something isn't related to diabetes. They're often so distracted by the diabetes that they just don't listen.

New Living BioBank Matches Diabetes Patients with Researchers

By MikeH on March 26, 2015
I'm pretty excited about a new diabetes research tool that's a little like an online dating service, in this case matching diabetes patients and researchers. It's called the Living BioBank, established by the nonprofit T1D Exchange, and it's about finding clinical research to participate in.

Some Good News About Lipohypertrophy + Continuous Glucose Monitoring (!)

By AmyT on March 25, 2015
Lipohypertrophy is one of those big words for bad side effects of diabetes that no one ever warns you about. Honestly, we never thought we’d ever have anything good to say about lipohypertrophy… until hearing about a recent study at Stanford University with surprising results:

An Interview with New ADA Chief Kevin Hagan

By MikeH on March 24, 2015
Today we have an interview with the American Diabetes Association's new CEO Kevin Hagan, who was named on Feb. 19 and takes over the helm June 1. Hagan replaces Dr. Suzanne Berry, the interim leader following the departure of former CEO Larry Hausner in August 2014.


More on Diabetes Mine

DiabetesMine Accolades

"... A respected site that helps you keep up with what's moving and shaking in the diabetes world"
— The New York Times'

Share this